Andrew J. Vickers, DPhil; David M. Kent, MD, CM, MSc
Grant Support: In part by funds from David H. Koch provided through the Prostate Cancer Foundation, the Sidney Kimmel Center for Prostate and Urologic Cancers, and the National Cancer Institute (P50-CA92629 [Specialized Programs of Research Excellence grant] and P30-CA008748 [to Memorial Sloan Kettering Cancer Center]). Additional support was provided by the National Institutes of Health (grant U01 NS086294), the Patient-Centered Outcomes Research Institute (grant 1IP2PI000722), and a Clinical & Translational Science Awards U-award (UL1 TR001064).
Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M14-2767.
Requests for Single Reprints: Andrew J. Vickers, DPhil, Memorial Sloan Kettering Cancer Center, 307 East 63rd Street, 2nd Floor, New York, NY 10065; e-mail, email@example.com.
Current Author Addresses:Dr. Vickers: Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 485 Lexington Avenue, 2nd Floor, New York, NY 10017.
Dr. Kent: Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, 800 Washington Street, Boston, MA 02111.
Vickers AJ, Kent DM. The Lake Wobegon Effect: Why Most Patients Are at Below-Average Risk. Ann Intern Med. 2015;162:866–867. doi: 10.7326/M14-2767
Download citation file:
Published: Ann Intern Med. 2015;162(12):866-867.
Cancer Screening/Prevention, Hematology/Oncology, Lung Cancer, Prevention/Screening, Prostate Cancer.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use